We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy ... Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused, and coordinated innate and adaptive immune response. Show more
- SNS-101 initial Phase 1 clinical data presented at SITC demonstrate potential best-in-class safety and pharmacokinetic profile, with no cytokine release syndrome or dose-limiting toxicities...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.08 | 8.51063829787 | 0.94 | 1.1 | 0.9101 | 54842 | 0.9784657 | CS |
4 | -0.04 | -3.77358490566 | 1.06 | 1.17 | 0.9101 | 97443 | 1.03681997 | CS |
12 | 0.22 | 27.5 | 0.8 | 1.22 | 0.74 | 75327 | 0.97670866 | CS |
26 | 0.4303 | 72.969306427 | 0.5897 | 1.22 | 0.51 | 72197 | 0.83909635 | CS |
52 | -0.42 | -29.1666666667 | 1.44 | 1.72 | 0.51 | 46996 | 0.91232113 | CS |
156 | -12.17 | -92.26686884 | 13.19 | 15.12 | 0.51 | 75539 | 4.52212016 | CS |
260 | -23.68 | -95.8704453441 | 24.7 | 26.38 | 0.51 | 86193 | 6.96663216 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions